‘No-Deal’ Brexit: First Govt Docs This Week May Show Impact On Life Sciences
Executive Summary
The BioIndustry Association says life sciences could be among the first sectors to be addressed in the UK government’s planned release of “technical notices” regarding the effects of a “no-deal” Brexit.
You may also be interested in...
Lack Of National Planning For No-Deal Brexit Makes UK Device Shortages More Likely
The trade association, NHS Providers, has warned of shortages and stockpiles of medical devices in the UK, as well as problems with public health and disease control, if contingency planning for a “no-deal” Brexit is not coordinated at a national level.
Lack Of National Planning For No-Deal Brexit Makes UK Drug Shortages More Likely
The trade association, NHS Providers, has warned of shortages and stockpiles of medicines in the UK, as well as problems with public health and disease control, if contingency planning for a “no-deal” Brexit is not coordinated at national level.
UK Regulatory Changes During A Brexit Transition Period – The Government Explains All
Guidance documents on the regulation of medicines in the UK during a Brexit transition period have been published by the government, covering areas like batch release, drug approvals, and the role of the UK MHRA in the EU regulatory system.